Casandra
Casandra Test Code QD05868Version 1 (DRAFT)
Performing Lab
CD30, IHC with Interpretation
Clinical Use
Order TestUse
CD30 (Ki‑1) is a marker of lymphocyte activation and is characteristic of immunoblastic B‑cell or anaplastic T‑cell malignant lymphomas.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (IHC)
Biomarkers
CD30
ProteinIHC
Expression • Ordinal Score (e.g., TPS, CPS, H-score)
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Paraffin block bag
Causes for Rejection
Received frozen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinite |
| Refrigerated | Indefinite |
Similar Tests
Other tests from different labs that may be relevant
CD30 Immunohistochemistry (IHC)
NeoGenomics
CD30 by Immunohistochemistry
ARUP Laboratories
CD30
MPLN
CD30, technical only
MPLN
CD30 Immunostain, Technical Component Only
Mayo Clinic Lab
CD30 for Bone Marrow Specimens by Immunohistochemistry
ARUP Laboratories
CD25 Immunohistochemistry (IHC)
NeoGenomics
CD38 Immunohistochemistry (IHC)
NeoGenomics
CD4
NeoGenomics
CD20 Immunohistochemistry (IHC)
NeoGenomics